University Health Network
- Country
- π¨π¦Canada
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uhn.ca
3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2004-03-09
- Last Posted Date
- 2018-09-14
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 26
- Registration Number
- NCT00078975
- Locations
- π¨π¦
Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
π¨π¦Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada
π¨π¦London Regional Cancer Program at London Health Sciences Centre, London, Ontario, Canada
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
- Conditions
- Head and Neck CancerProstate CancerBreast CancerCervical CancerSarcoma
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2018-02-22
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT00004261
- Locations
- π¨π¦
Princess Margaret Hospital, Toronto, Ontario, Canada
UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Conditions
- Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT00072267
- Locations
- π¨π¦
Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada
π¨π¦Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
π¨π¦Princess Margaret Hospital, Toronto, Ontario, Canada
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
- Conditions
- Transitional Cell Cancer of the Renal Pelvis and UreterBladder Cancer
- First Posted Date
- 2003-08-07
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT00066352
- Locations
- π¨π¦
Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
πΊπΈDecatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States
π¨π¦Princess Margaret Hospital, Toronto, Ontario, Canada
Perifosine in Treating Patients With Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT00053924
- Locations
- π¨π¦
Princess Margaret Hospital, Toronto, Ontario, Canada
π¨π¦Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
π¨π¦Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada
Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT00054145
- Locations
- π¨π¦
Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada
π¨π¦Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada
π¨π¦Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 16
- Registration Number
- NCT00045669
- Locations
- πΊπΈ
Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, United States
πΊπΈLaGrange Memorial Hospital, LaGrange, Illinois, United States
πΊπΈUniversity of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States
UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
- Conditions
- Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-06-23
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 33
- Registration Number
- NCT00045175
- Locations
- π¨π¦
Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada
π¨π¦Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
π¨π¦Princess Margaret Hospital, Toronto, Ontario, Canada
Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
- Conditions
- LeukemiaLymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT00045513
- Locations
- π¨π¦
Princess Margaret Hospital at University Health Network, Toronto, Ontario, Canada
π¨π¦McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada
π¨π¦London Health Sciences Centre, London, Ontario, Canada
Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer
- Conditions
- Colorectal Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT00052507
- Locations
- π¨π¦
Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada
π¨π¦Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada
π¨π¦Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada